Early research (Phase 1)Looking for participantsNCT05870579
What this trial is testing
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 48